Part D prescriber enrollment requirement delayed to 2019

CMS has announced it will push back a requirement for prescribers be enrolled in Medicare for Part D to cover their prescriptions, marking at least the fourth time the agency has delayed the rule since it was finalized in March 2014.

“While CMS is committed to the implementation of the prescriber enrollment requirements, CMS also recognizes the need to minimize the impact on the beneficiary population and ensure beneficiaries have access to the care they need,” the agency said in a press release.

Full enforcement of the rule will now begin on Jan. 1, 2019, pushed back from Feb. 1, 2017. Beginning in the second quarter of 2017, however, CMS said it will “begin phasing in targeted enforcement of the regulation, beginning with prescribers who are currently excluded from Medicare by HHS’ Office of the Inspector General (OIG) or have a felony conviction within the last 10 years.

Along with the selective enforcement, CMS will also push for prescribers to enroll with an “easy enroll application process” and direct emails to prescribers of Schedule II drugs and, beginning later in 2017, all non-enrolled prescribers.

In the lead-up to the January 1, 2019 full enforcement date, CMS will begin phasing in targeted enforcement of the regulation and undertake the following incremental strategic actions designed to increase on-going prescriber enrollment, while protecting beneficiaries and the Medicare program.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”